Drug Profile
Neutral metoclopramide
Alternative Names: Neu-Sensamide; nMCALatest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator OXiGENE
- Class Aminobenzoic acids; Antiemetics; Antineoplastics; Benzamides; Chlorobenzenes; Diethylamines; Gastrokinetics; Phenyl ethers; Radiation-sensitising agents; Radiosensitisers; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Glioma; Non-small cell lung cancer; Squamous cell cancer
Most Recent Events
- 16 Feb 1999 Discontinued-I for Glioma in European Union (IM)
- 16 Feb 1999 Discontinued-I for Glioma in USA (IM)
- 16 Feb 1999 Discontinued-II for Non-small cell lung cancer in USA (IM)